Michael J. Farrell - Aug 18, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role: Chief Executive Officer
Signature: Michael J. Farrell, Chief Executive Officer
Stock symbol: RMD
Transactions as of: Aug 18, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/22/2022, 03:06 PM
Previous filing: Aug 17, 2022
Next filing: Sep 19, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RMD	ResMed Common Stock	Award	$0	+17.3K	+4.27%	$0.00	423K	Aug 18, 2022	Direct	F1
holding	RMD	ResMed Common Stock						3.88K	Aug 18, 2022	Lisette and Michael Farrell Foundation
holding	RMD	ResMed Common Stock						5.09K	Aug 18, 2022	Lisette and Michael Farrell Family Trust

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance-based restricted stock units granted on November 18, 2021. The shares were earned on August 18, 2022, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.